Prices
ATS Login
Learn more
Home
Tables by benefits - sickness/health care function
methods, notes and classification
Tables by benefits - sickness/health care function
methods, notes and classification
Methods
Variables
Download
ESSPROS-expenditure
00
Social protection benefits
01
Non means-tested benefits
02
Means-tested benefits
03
Cash benefits
04
Cash benefits (non means-tested)
05
Cash benefits (means-tested)
06
Periodic cash benefits
07
Periodic cash benefits (non means-tested)
08
Periodic cash benefits (means-tested)
09
Paid sick leave benefit
0a
Paid sick leave benefit (non means-tested)
0b
Paid sick leave benefit (means-tested)
0c
Other periodic cash benefits
0d
Other periodic cash benefits (non means-tested)
0e
Other periodic cash benefits (means-tested)
0f
Lump sum cash benefits
0g
Lump sum cash benefits (non means-tested)
0h
Lump sum cash benefits (means-tested)
0i
Other lump sum cash benefits
0j
Other lump sum cash benefits (non means-tested)
0k
Other lump sum cash benefits (means-tested)
0l
Benefits in kind
0m
Benefits in kind (non means-tested)
0n
Benefits in kind (means-tested)
0o
In-patient care
0p
In-patient care (non means-tested)
0q
In-patient care (means-tested)
0r
In-patient care direct provision
0s
In-patient care direct provision (non means-tested)
0t
In-patient care direct provision (means-tested)
0u
In-patient care reimbursment
0v
In-patient care remboursment (non means-tested)
0w
In-patient care remboursment (means-tested)
0x
Out-patient care
0y
Out-patient care (non means-tested)
0z
Out-patient care (means-tested)
10
Out-patient care direct provision of pharmaceutical products
11
Out-patient care direct provision of pharmaceitical products (non means-tested)
12
Out-patient care direct provision of pharm. products (means-tested)
13
Out-patient care other direct provision
14
Out-patient care other direct provision (non means-tested)
15
Out-patient care other direct provision (means-tested)
16
Out-patient care reimbursment of pharmaceutical products
17
Out-patient care rembursment of pharmaceutical products (non means-tested)
18
Out-patient care rembursment of pharmaceutical products (means-tested)
19
Out-patient care other reimbursment
1a
Out-patient care other rembursment (non means-tested)
1b
Out-patient care other rembursment (means-tested)
1c
Other benefits in kind
1d
Other benefits in kind (non means-tested)
1e
Other benefits in kind (means-tested)
ESSPROS-category of schemes
0
All schemes
Unit of measure
00
Million euro
01
Euro per inhabitant (at constant 2010 prices)
02
Million units of national currency
03
Million purchasing power standards (PPS)
04
Purchasing power standard (PPS) per inhabitant
05
Percentage of gross domestic product (GDP)
Geopolitical entity (reporting)
000
European Union - 27 countries (from 2020)
001
European Union - 28 countries (2013-2020)
002
European Union - 27 countries (2007-2013)
003
European Union - 15 countries (1995-2004)
004
Euro area – 20 countries (from 2023)
005
Euro area - 19 countries (2015-2022)
006
Euro area - 18 countries (2014)
007
Euro area - 12 countries (2001-2006)
008
Belgium
009
Bulgaria
00a
Czechia
00b
Denmark
00c
Germany
00d
Estonia
00e
Ireland
00f
Greece
00g
Spain
00h
France
00i
Croatia
00j
Italy
00k
Cyprus
00l
Latvia
00m
Lithuania
00n
Luxembourg
00o
Hungary
00p
Malta
00q
Netherlands
00r
Austria
00s
Poland
00t
Portugal
00u
Romania
00v
Slovenia
00w
Slovakia
00x
Finland
00y
Sweden
00z
European Economic Area (EEA18-1995, EEA28-2004, EEA30-2007, EEA31-2013, EEA30-2020)
010
Iceland
011
Norway
012
Switzerland
013
United Kingdom
014
Bosnia and Herzegovina
015
Montenegro
016
North Macedonia
017
Albania
018
Serbia
019
Türkiye